Nath Bio-Genes (India) Limited

Company Profile

Nath Bio-Genes (India) Limited had its IPO on under the ticker symbol 537291.

The company operates in the Other sector and Other industry. Nath Bio-Genes (India) Limited has a staff strength of 0 employees.

Stock update

Shares of Nath Bio-Genes (India) Limited opened at ₹227.35 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹210.55 - ₹227.35, and closed at ₹212.9.

This is a -5.84% slip from the previous day's closing price.

A total volume of 23,020 shares were traded at the close of the day’s session.

In the last one week, shares of Nath Bio-Genes (India) Limited have increased by +2.26%.

Nath Bio-Genes (India) Limited's Key Ratios

Nath Bio-Genes (India) Limited has a market cap of ₹6.24 billion, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months Nath Bio-Genes (India) Limited’s revenue was ₹0 with a gross profit of ₹0 and an EBITDA of ₹0. The EBITDA ratio measures Nath Bio-Genes (India) Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Nath Bio-Genes (India) Limited’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q0.33333333333333, Nath Bio-Genes (India) Limited’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Nath Bio-Genes (India) Limited’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Nath Bio-Genes (India) Limited’s profitability.

Nath Bio-Genes (India) Limited stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

Nath Bio-Genes (India) Limited stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹7.93 billion

Total Liabilities

₹2.16 billion

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

0%

Nath Bio-Genes (India) Limited ended 2024 with ₹7.93 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹7.93 billion while shareholder equity stood at ₹5.73 billion.

Nath Bio-Genes (India) Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹2.16 billion in other current liabilities, 190040000.00 in common stock, ₹5.54 billion in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹379.95 million and cash and short-term investments were ₹379.95 million. The company’s total short-term debt was ₹1,040,790,000 while long-term debt stood at ₹4.03 million.

Nath Bio-Genes (India) Limited’s total current assets stands at ₹5.21 billion while long-term investments were ₹0 and short-term investments were ₹1.71 billion. Its net receivables were ₹973.14 million compared to accounts payable of ₹277.36 million and inventory worth ₹2.08 billion.

In 2024, Nath Bio-Genes (India) Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, Nath Bio-Genes (India) Limited paid ₹0 in dividends in 2024.

Other key metrics

Current Trading Price

₹212.9

52-Week High

₹243.7

52-Week Low

₹126.9241

Analyst Target Price

₹

Nath Bio-Genes (India) Limited stock is currently trading at ₹212.9 per share. It touched a 52-week high of ₹243.7 and a 52-week low of ₹243.7. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹216.08 and 200-day moving average was ₹174.6 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.